An expansive biomarker study confirmed OV329 delivered statistically significant inhibition of GABA-AT as measured across ...

BOSTON and LONDON, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Miley Cyrus says she may have been “the first person to maybe ever be canceled,” recalling the backlash from parents during ...

Rolling Stone magazine gave the singer's new music project an impressive five stars. "Taylor Swift's 'The Life of a Showgirl' ...

International Flavors & Fragrances Inc. (NYSE:IFF) is one of the best buy-the-dip stocks to buy, according to analysts. On September 9, the company unveiled a new platform as it moves to inspire ...

Obesity has been linked to diseases like diabetes, heart disease, and hypertension for a long time. Excess weight is now linked directly to Alzheimer’s in a new study — with tiny messengers going back ...

Vivani expects to reestablish and announce a new record date as soon as possible. ThinkEquity is acting as the exclusive ...

Research hub Imec has demonstrated a beyond-110 GHz C-band silicon-germanium (SiGe) electro-absorption modulator (EAM) that is manufactured on its 300 mm silicon photonics platform. The R&D firm said ...

Investing.com -- Ovid Therapeutics Inc. (NASDAQ:OVID) stock soared 20% after the company announced positive topline results for its next-generation GABA-aminotransferase inhibitor, OV329, ...

This valuable study identifies a brown adipose tissue-specific heat shock factor 1-alcohol dehydrogenase 5 (ADH5) molecular cascade as a regulator of systemic aging, showing that ADH5 deficiency ...

The study aims to help people with speech and mobility challenges use the companies' technologies to interact using brain ...